v3 Template
B

Beacon Biosignals

Healthcare and Neurotechnology ~340 employees
Founded
--
Employees (Est.)
~340
17 leaders known
Total Funding
$183.0M
Funding Rounds
2
Last Funding
2026-04-06

About Beacon Biosignals

Beacon Biosignals is dedicated to advancing brain health through AI-driven neurotechnology. Their mission is to bring precision neuroscience to clinical trials, accelerating drug development for neurological and psychiatric conditions to deliver life-changing treatments to patients faster.

Products & Services

Waveband:An FDA-cleared headband for high-fidelity sleep EEG capture at home or in clinical settings.
Datastore:A component of their platform for managing EEG data.
Beacon HQ:Analytics software for monitoring compliance and treatment responses in clinical trials.
Clinical Study Operations:Full-service support for device setup, software integration, and data quality in clinical trials.
Scientific Services:Expertise in reporting and scientific support across drug development stages.
Beacon Platform:An end-to-end solution for EEG biomarkers in clinical research, integrating AI models trained on extensive EEG data to characterize brain function.
Dreem 3S headband
Beacon Platform
Analytics software

Specialties

AI-Driven Neurotechnology Precision Neuroscience EEG Biomarkers Sleep Analysis Clinical Trial Optimization Drug Development for Neurological and Psychiatric Conditions EEG biomarkers Quantitative sleep analysis Clinical trial optimization Pharmacodynamic biomarkers Patient stratification

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Series B
T: -
FT: Series B
A: 97000000
MR: -
FA: 97 million
FAN: 97000000
D: 2026-04-06
FD: 2026-04-06
12 investors
2 RT: Series B
T: -
FT: Series B
A: 86000000
MR: -
FA: 86 million
FAN: 86000000
D: 2025-11-13
FD: 2025-11-13
10 investors
Series B Latest
2026-04-06
$97.0M
12 investors (Pro only)
Series B 2025-11-13
$86.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

J

Jacob Donoghue

CEO & Co-Founder

J

Jarrett Revels

CTO & Co-Founder

M

Matt Alkaitis

Chief Clinical Officer

D

David Matthews

Chief Business Officer

A

Alexander Chan

VP of Analytics and Machine Learning

A

Allison Braly

VP of Clinical Strategy and Operations

View 14 more team members with Pro

Unlock Full Team Directory

Recent News

Beacon Biosignals Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Website
beacon.bio
Industries
Healthcare and Neurotechnology
Company Size
~340 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro